News
Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel...
Sanofi has entered into a co-exclusive licensing agreement with Novavax.
The terms of the agreement include: a co-exclusive license to co-commercialize Novavax’s current stand-alone adjuvanted...
iECURE receives FDA Fast Track designation for neonatal onset Ornithine Transcarbamylase (OTC) deficiency treatment
iECURE, a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies for the treatment of liver...
Flagship Pioneering and Metaphore Biotechnologies collaborate with Novo Nordisk to develop next-generation obesity management...
Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, has joined Flagship Pioneering in a research collaboration...
